Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen's Parsabiv Approved With Unusual Postmarketing Requirements

Feb 13 2017

• By Michael Cipriano

Puzzle

Related Content

Amgen's Parsabiv's EU Approval Contrasts With US FDA Rejection

Nov 17 2016

Amgen's Parsabiv's Gets EU Approval While It Languishes At The FDA

Nov 17 2016

Amgen's Reticence On Parsabiv Complete Response Letter Revives Transparency Issue

Aug 25 2016

Amgen Gets Parsabiv CRL, Gives No Clues As To Why

Aug 25 2016

Related Companies

Amgen, Inc.

AbbVie Inc.

Sprout Pharmaceuticals, Inc.

Marathon Pharmaceuticals LLC

Additional Topics

United States Approvals Post Market Regulation & Studies Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window